Fieldpoint Private Securities’s DexCom DXCM Stock Holding History

Fieldpoint Private Securities’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$1K	Sell	8 -52	-87%	-$4.75K	﹤0.01%	1323
2022 Q1	$8K	Buy	60 +40	+200%	+$4.38K	﹤0.01%	1144
2021 Q4	$3K	Sell	20 -60	-75%	-$8.62K	﹤0.01%	1388
2021 Q3	$11K	Hold	80	–	–	﹤0.01%	1008
2021 Q2	$10K	Hold	80	–	–	﹤0.01%	1011
2021 Q1	$7K	Sell	80 -304	-79%	-$28.5K	﹤0.01%	1095
2020 Q4	$35K	Buy	+384	New	+$34.3K	0.01%	543
2020 Q1	–	Sell	-68	Closed	-$4K	–	335
2019 Q4	$4K	Buy	68 +8	+13%	+$379	﹤0.01%	610
2019 Q3	$2K	Buy	+60	New	+$2.33K	﹤0.01%	676
2017 Q4	–	Sell	-3,656	Closed	-$45K	–	435
2017 Q3	$45K	Buy	+3,656	New	+$64.6K	0.02%	402

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fieldpoint Private Securities's DXCM Position: Q2 2022 in Review

Fieldpoint Private Securities reduced its DexCom (DXCM) stake by 87% in Q2 2022, selling an estimated $4.75K and leaving 8 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1323.

Fieldpoint Private Securities first reported a position in DXCM in Q3 2017 and has held it in 10 quarters since. The position peaked at $45K in Q3 2017. 798 funds tracked by Wall St. Rank hold DXCM as of Q2 2022.

Fieldpoint Private Securities held 8 shares of DexCom worth $1K as of Q2 2022.
Fieldpoint Private Securities sold 52 DexCom shares in Q2 2022, an estimated $4.75K.
DexCom made up ﹤0.01% of Fieldpoint Private Securities's portfolio in Q2 2022, its #1323 holding.
Fieldpoint Private Securities first reported a position in DexCom in Q3 2017 and has held it in 10 quarters since.
Fieldpoint Private Securities's DexCom position peaked at $45K in Q3 2017.
798 funds tracked by Wall St. Rank held DexCom as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.